Replies to post #365004 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks for the numbers. DRL has now surpassed Hikma.
Sleven,

[studythosestocks]

Thx Raf.
Not terrible.
I was expecting about 71K.
We’ll see after the holidays if an upward trend is the new trend instead of flat/slightly downward trend.
Have a great 2022 and appreciate all you do keeping us informed on many levels.

[Jasbg]

raf, Thanks - red all around as expected.

Seems like Reddy is moving in on Hikma fast. And what we sometime maybe forget somewhat - a company like DR Reddy is gigantic - compared to Amarin.

Generic Vascepa is 'just another introduced product' for Reddy - they have 'running litigation' forever an always - part of how Generics operate.

https://en.wikipedia.org/wiki/Dr._Reddy%27s_Laboratories

It will be very' very' exiting to se if Marjac - will be able to 'break down' the defense line of these 'top pro companies 'with dozens of high paid Lawyers specialized in not at least 'patent law'.
---------------------------------

If Marjac succeed in this task - he will potentially 'change the course' of US Law practice - evaluating entrance of generic drugs into the market.

But we all have to acknowledge - that Marjac are up against 'an industry that has become 'Big Money and Power'.

Generic Drug-industry. They are not going to 'take this' - without fighting back (lobbyism - trolls everywhere possible).

[rafunrafun]

Scripts for week ending December 31, 2021 - New Year's Eve

Drug Industry TRx: -3.4% w/w

Vascepa
TRx 72,023; -3.1% (-2,291) w/w; -13.8% y/y
NRx 29,703; -11.9% (-4,012) w/w; -12.5% y/y
Ref 42,320; +4.2% (+1,721) w/w; -14.7% y/y

Lovaza (Generic & Brand)
TRx 57,625; -3.9% (-2,337) w/w; -6.4% y/y
NRx 26,719; -10.9% (-3,277) w/w; -7.4% y/y
Ref 30,906; +3.1% (+940) w/w; -5.6% y/y

Generic Vascepa
TRx 22,642; -6.2% (-1,501) w/w; As % of total V: 23.9%
NRx 12,088; -15.9% (-2,290) w/w; As % of total V: 28.9%
Ref 10,553; +8.1% (+789) w/w; As % of total V: 20.0%

Generic Vascepa by Manufacturer
Hikma - TRx 11,934 (-100); Generic share 52.7%; Total V share 12.6%
Reddy - TRx 10,704 (-1,405); Generic share 47.3%; Total V share 11.3%
Apotex - TRx 3 (+3); Generic share 0%; Total V share 0%

Vascepa + Generic Vascepa
TRx 94,664; -3.9% (-3,792) w/w; +8.3% y/y
NRx 41,791; -13.1% (-6,303) w/w; +16.8% y/y
Ref 52,873; +5.0% (+2,510) w/w; 2.5% y/y